Wegovy contains the same main ingredient as Ozempic, semaglutide, and is FDA-approved for weight loss in people with obesity or who are overweight with at least one weight-related condition. It is ...

To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...

Once again, Eli Lilly is using Hollywood’s biggest night as a platform to speak out on a hot-button issue in pharma. | Once ...

The ad features a vial that reads "compounded semaglutide" and a syringe. "Some compounded semaglutide vials have been found to contain dangerous impurities, banned substances, or incorrect doses.

Compounded GLP-1s have given rise to a cottage industry offering cheaper weight loss medications to many Americans — but now ...

Hims & Hers saw a massive YTD surge, but FDA news led to a pullback. Find out why HIMS stock is still undervalued and why ...

After years of weight loss drug shortages, the FDA is saying there’s now an adequate supply for most medications and they ...

Researchers analysed data from 150 adults with T1D, divided into semaglutide, tirzepatide, and control groups.

Although the telemedicine company displayed blistering growth and issued robust guidance, shares of Hims & Hers (NYSE: HIMS) ...

After the FDA removed semaglutide injection products from a shortage list, compounders like Hims have 60-90 days to stop making copies.